Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

EGX:PHAR Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 30, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,247	6,829	5,430	3,621	4,155	4,309
Market Cap Growth	93.13%	25.78%	49.96%	-12.86%	-3.57%	-34.63%
Enterprise Value	21,595	14,578	9,630	5,388	5,509	5,532
Last Close Price	78.50	43.17	32.68	23.71	25.05	24.17
PE Ratio	10.54	6.23	6.60	5.63	8.52	8.86
Forward PE	10.34	7.03	5.92	5.77	6.23	7.52
PS Ratio	1.43	0.90	1.04	0.92	1.22	1.49
PB Ratio	2.04	1.47	1.27	1.12	1.40	1.51
P/TBV Ratio	2.15	1.48	1.28	1.12	1.40	1.52
P/OCF Ratio	23.30	-	58.71	-	10.83	26.14
PEG Ratio	-	4.15	4.15	4.15	4.15	4.15
EV/Sales Ratio	2.32	1.92	1.84	1.36	1.62	1.92
EV/EBITDA Ratio	8.56	9.12	7.33	7.10	6.35	7.61
EV/EBIT Ratio	8.93	9.70	7.95	8.14	7.09	9.42
EV/FCF Ratio	-14.81	-	-	-	-	-
Debt / Equity Ratio	1.42	1.98	1.15	0.88	0.59	0.63
Debt / EBITDA Ratio	3.89	5.76	3.74	3.76	2.03	2.47
Asset Turnover	0.58	0.60	0.63	0.66	0.66	0.61
Inventory Turnover	1.46	1.46	1.36	1.21	1.08	1.03
Quick Ratio	0.47	0.45	0.65	0.54	0.67	1.02
Current Ratio	1.43	1.38	1.94	1.72	2.13	2.13
Return on Equity (ROE)	22.48%	24.60%	21.95%	20.71%	16.78%	16.81%
Return on Assets (ROA)	8.83%	7.41%	9.04%	6.89%	9.46%	7.77%
Return on Invested Capital (ROIC)	11.71%	10.36%	13.21%	10.69%	14.11%	13.37%
Return on Capital Employed (ROCE)	20.10%	15.80%	16.90%	16.10%	21.70%	17.70%
Earnings Yield	9.49%	16.04%	15.14%	17.76%	11.74%	11.29%
FCF Yield	-11.00%	-60.34%	-40.48%	-23.75%	-1.28%	-0.90%
Dividend Yield	1.89%	3.48%	3.06%	4.22%	5.99%	-
Payout Ratio	48.57%	39.61%	37.67%	61.14%	78.64%	103.41%
Buyback Yield / Dilution	-13.45%	-	-50.00%	-	-1.64%	1.61%
Total Shareholder Return	-11.56%	3.48%	-46.94%	4.22%	4.35%	1.61%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.